SR9009 Solution, 600mg (20mg/mL)
Sarms Australia Stenabolic SR9009
SR9009 Stenabolic Chemistry

SR9009 Solution, 600mg (20mg/mL)

AUD $149.00

Clinical research has shown that SR9009 may have the ability to;

✓ Increase endurance and reduce recovery time.
✓ Burn fat by increasing glucose uptake in skeletal muscle tissue.
✓ Increase resting metabolic rate.
✓ Reduce inflammation and prevent oxidative damage to blood vessels.

 

Note: Products are for laboratory research use only. Not for human use. Reference Materials are not therapeutics and we do not sell to patients.

In stock

BULK PRICING
1 2-4 5-9 10-19 20+
AUD $149.00 AUD $146.50 AUD $144.00 AUD $139.00 AUD $129.00
Return or exchange your unopened product within 30 days. The highest quality and most trusted in Australia. Returns can be sent to our Australian warehouse. Our checkout is SSL encrypted and completely secure. Domestic same day express shipping, quick and fast. Our products are verified by independent third party laboratories to meet quality standards. All product batches and lots are assigned unique identifiers so there is always traceability.
Category:
000
CAS 1379686-30-2
Molar Mass 437.94 g/mol
Chemical Formula C20H24ClN3O4S
IUPAC Name ethyl 3-[[(4-chlorophenyl)methyl-[(5-nitrothiophen-2-yl)methyl]amino]methyl]pyrrolidine-1-carboxylate
Synonyms SHRED, Sr9009, SR-9009, SR 9009, Stenabolic
Storage Room temperature
Country of Origin USA
Standard 20mg/mL ±10%
Terms of sale This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Information presented is based upon evidence found in clinical studies. Please familiarise yourself with our Terms & Conditions prior to ordering.

Although Stenabolic SR9009 is usually grouped into the category of SARMS, it is actually a PPAR modulator. It works by activating AMP-activated protein kinase and stimulating glucose uptake in skeletal muscle tissue. Stenabolic (SR9009) has been studied for its ability to reverse metabolic disorders and was considered as a treatment for obesity. It was shown to be very successful in this regard.
When used in clinical trials, Stenabolic (SR9009) was shown to increase the subjects resting metabolic rate, while positively influencing lipid and glucose metabolism in the liver.

SR 9009 was also shown to impact the reaction of macrophages. Macrophages are cells that eliminate dead and dying cells from the body during inflammation

In Vivo:
Studies of Stenabolic (SR9009) suggest dosages can be approximately  10mg, twice per day – due to a shorter half life.

Studies and additional info:
https://newatlas.com/scripps-drug-sr9009-exercise-mimic/28651/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3343186/
https://www.ncbi.nlm.nih.gov/pubmed/25536025
https://www.ncbi.nlm.nih.gov/pubmed/22460951

Related products